A detailed history of Moody Aldrich Partners LLC transactions in Insmed Inc stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 35,478 shares of INSM stock, worth $2.78 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
35,478
Holding current value
$2.78 Million
% of portfolio
0.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$66.29 - $76.63 $2.35 Million - $2.72 Million
35,478 New
35,478 $2.45 Million
Q1 2018

Apr 26, 2018

SELL
$21.69 - $32.99 $673,387 - $1.02 Million
-31,046 Closed
0 $0
Q4 2017

Jan 31, 2018

BUY
$26.43 - $31.78 $170,896 - $205,489
6,466 Added 26.31%
31,046 $968,000
Q3 2017

Nov 13, 2017

BUY
$11.61 - $31.21 $285,373 - $767,141
24,580
24,580 $767,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.